首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >High thoracic epidural anesthesia in coronary artery bypass surgery: a propensity-matched study.
【24h】

High thoracic epidural anesthesia in coronary artery bypass surgery: a propensity-matched study.

机译:冠状动脉搭桥手术中的高胸腔硬膜外麻醉:一项倾向匹配研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To assess if 2 different anesthesia strategies, high-thoracic epidural anesthesia (HTEA) plus inhalation anesthesia and total intravenous anesthesia (TIVA) with sufentanil/propofol had different influence on outcomes of coronary artery bypass graft (CABG) surgery patients. DESIGN: Retrospective comparison of outcomes between HTEA and TIVA patients using propensity score pair-wise matching of patients. SETTING: A university teaching hospital. Participants: A study of 1,473 consecutive patients undergoing elective CABG surgery; of these, 476 (32%) received HTEA combined with inhalation anesthesia, whereas 997 (68%) underwent TIVA alone. INTERVENTIONS: The patients undergoing CABG surgery were offered the epidural-inhalation anesthetic approach. MEASUREMENTS AND MAIN RESULTS: Propensity matching yielded 389 pairs of patients. Patients were well matched in preoperative and operative features. Postoperative mortality, myocardial infarction, stroke, acute renal failure rates, and intensive care unit (ICU) stay were not statistically different in HTEA and TIVA groups. On the other hand, patients treated with HTEA had shorter ventilation times (5.8 +/- 3.11 v 6.9 +/- 5.0 hours, HTEA and TIVA, respectively, p < 0.001); in addition, vasoconstrictors were more frequently used in cases of HTEA, whereas vasodilators were mainly used with TIVA both intra- and postoperatively. No neurologic complications related to the use of HTEA were observed. CONCLUSIONS: HTEA and TIVA provided similar early outcomes after CABG surgery, and there were no major differences between these 2 strategies in the average risk CABG patient populations. Although HTEA did not cause neurologic problems and yielded a significant reduction in time to extubation, a consistent benefit over standard techniques could not be shown.
机译:目的:为了评估两种不同的麻醉策略,高胸腔硬膜外麻醉(HTEA)加吸入麻醉和舒芬太尼/丙泊酚全静脉麻醉(TIVA)对冠状动脉搭桥术(CABG)手术患者的结局有不同的影响。设计:使用患者的倾向评分成对匹配,对HTEA和TIVA患者的结局进行回顾性比较。地点:一所大学教学医院。参与者:对1,473例行CABG择期手术的患者进行了研究;其中,476(32%)人接受了HTEA联合吸入麻醉,而997(68%)人单独接受了TIVA。干预措施:为接受CABG手术的患者提供了硬膜外吸入麻醉方法。测量和主要结果:倾向匹配产生了389对患者。患者的术前和术中特征非常匹配。 HTEA和TIVA组的术后死亡率,心肌梗塞,中风,急性肾衰竭发生率和重症监护病房(ICU)停留时间无统计学差异。另一方面,接受HTEA治疗的患者通气时间较短(分别为5.8 +/- 3.11 v 6.9 +/- 5.0小时,HTEA和TIVA,p <0.001)。此外,在HTEA病例中更经常使用血管收缩剂,而在术中和术后主要使用TIVA血管扩张剂。没有观察到与使用HTEA相关的神经系统并发症。结论:HTEA和TIVA在CABG手术后提供了相似的早期结果,在平均风险CABG患者人群中,这两种策略之间没有重大差异。尽管HTEA不会引起神经系统问题,并且可以显着减少拔管时间,但仍无法证明其优于标准技术的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号